NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category (Descending) | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
55513-0095-01 | 55513-0095 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0095-91 | 55513-0095 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0096-01 | 55513-0096 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0096-91 | 55513-0096 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0097-01 | 55513-0097 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0097-91 | 55513-0097 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Sept. 25, 2006 | Feb. 28, 2009 | No Longer Used | |||
55513-0110-01 | 55513-0110 | Darbepoetin alfa | Aranesp | 300.0 ug/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 14, 2006 | In Use | ||
55513-0111-01 | 55513-0111 | Darbepoetin alfa | Aranesp | 300.0 ug/.6mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Aug. 14, 2006 | In Use | ||
55390-0014-02 | 55390-0014 | Dexrazoxane | Dexrazoxane | Ancillary Therapy | Chemoprotective | Detoxifying Agent | March 31, 2005 | May 31, 2012 | No Longer Used | ||
55390-0060-02 | 55390-0060 | Dexrazoxane | Dexrazoxane | Ancillary Therapy | Chemoprotective | Detoxifying Agent | March 31, 2005 | May 31, 2013 | No Longer Used |
Found 10,000 results in 6 milliseconds — Export these results